HOWL (Werewolf Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Werewolf Therapeutics, Inc. Common Stock (HOWL) is a publicly traded Healthcare sector company. As of May 21, 2026, HOWL trades at $0.45 with a market cap of $24.07M and a P/E ratio of -0.34. HOWL moved +3.43% today. Year to date, HOWL is -32.03%; over the trailing twelve months it is -61.58%. Its 52-week range spans $0.40 to $4.18. Rallies surfaces HOWL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate HOWL?

The average price target is $0.00.

HOWL Key Metrics

Key financial metrics for HOWL
MetricValue
Price$0.45
Market Cap$24.07M
P/E Ratio-0.34
EPS$-1.32
Dividend Yield0.00%
52-Week High$4.18
52-Week Low$0.40
Volume2.37K
Avg Volume0
Revenue (TTM)$0
Net Income$-60.82M
Gross Margin0.00%

HOWL Analyst Consensus

HOWL analyst coverage data. Average price target: $0.00.

Latest HOWL News

Recent HOWL Insider Trades

  • EVNIN LUKE sold 85.89K (~$36.93K) on May 20, 2026.
  • EVNIN LUKE sold 62.97K (~$28.34K) on May 19, 2026.
  • EVNIN LUKE sold 22.18K (~$11.09K) on May 18, 2026.

Common questions about HOWL

What do analysts rate HOWL?
The average price target is $0.00.
Does Rallies show HOWL price targets?
Yes. Rallies tracks HOWL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is HOWL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOWL. It does not provide personalized investment advice.
HOWL

HOWL